Condition
Anemia Due to Intrinsic Red Cell Abnormality
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Cd34 Enriched T Cell Depleted Donor Stem Cell Product
Related Conditions
Often studied with 11 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Cd34 Enriched T Cell Depleted Donor Stem Cell Product1
Active Sponsors
- Christopher Dvorak1
Top Investigators
University of California, San Francisco
Related Conditions
- Cytopenias1
- Acute Lymphoblastic Leukemia1
- Acute Myeloid Leukemia1
- Bone Marrow Failure1
- Chronic Myeloid Leukemia1